Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA

  • Read more about TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA
Patent Cooperation Treaty
PCT/EP2022/068204
Filed on 2022-06-30

CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer

  • Read more about CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer
Japan
2022-135735
Filed on 2023-06-09

Compositions And Methods For Prevention Of Coronavirus Infection

  • Read more about Compositions And Methods For Prevention Of Coronavirus Infection
European Patent
21809656.8
Filed on 2021-05-18

Single Domain Antibodies Targeting HPV E6/E7 Oncogenic Peptide/MHC Complexes

  • Read more about Single Domain Antibodies Targeting HPV E6/E7 Oncogenic Peptide/MHC Complexes
Patent Cooperation Treaty
PCT/US2023/073144
Filed on 2023-08-30

CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

  • Read more about CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
US Application 18/346,680
Filed on 2023-07-03

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22

  • Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22
European Patent
22709092.5
Filed on 2023-09-13

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22

  • Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22
US Application 18/277,521
Filed on 2023-08-16

HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22

  • Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22
Canada
3207989
Filed on 2023-08-10

METHODS FOR TREATING BILE DUCT CANCERS WITH TIVOZANIB

  • Read more about METHODS FOR TREATING BILE DUCT CANCERS WITH TIVOZANIB
Patent Cooperation Treaty
PCT/US2021/060902
Filed on 2021-11-26

Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis

  • Read more about Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis
Taiwan
111139905
Filed on 2022-10-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 257
  • Page 258
  • Page 259
  • Page 260
  • Page 261
  • Page 262
  • Page 263
  • Page 264
  • Page 265
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health